Stay updated on LoDoNaVasc Clinical Trial
Sign up to get notified when there's something new on the LoDoNaVasc Clinical Trial page.

Latest updates to the LoDoNaVasc Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe clinical trial record for low-dose naltrexone in vasculitis is available again, with details of its placebo-controlled Phase 2 study and participant criteria. It indicates the study is completed and no longer recruiting, with no results posted.SummaryDifference57%

- Check17 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error rather than study details.SummaryDifference0.2%

- Check24 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434. It appears above the unavailable study record.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision identifier is updated from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the trial content. This indicates an access issue that hides the expected study information from users.SummaryDifference19%

Stay in the know with updates to LoDoNaVasc Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LoDoNaVasc Clinical Trial page.